Acadia Healthcare (NASDAQ:ACHC) Now Covered by Guggenheim

Guggenheim assumed coverage on shares of Acadia Healthcare (NASDAQ:ACHC) in a report published on Wednesday, Marketbeat.com reports. The firm issued a buy rating and a $36.00 price target on the stock.

ACHC has been the topic of a number of other reports. Bank of America dropped their price objective on Acadia Healthcare from $50.00 to $44.50 and set a “buy” rating on the stock in a research note on Friday, February 28th. StockNews.com cut shares of Acadia Healthcare from a “hold” rating to a “sell” rating in a research note on Monday, January 6th. TD Cowen reduced their target price on Acadia Healthcare from $70.00 to $66.00 and set a “buy” rating for the company in a research report on Tuesday, January 7th. KeyCorp lowered their price objective on Acadia Healthcare from $70.00 to $65.00 and set an “overweight” rating on the stock in a research note on Monday, March 3rd. Finally, Barclays lowered shares of Acadia Healthcare from an “overweight” rating to an “equal weight” rating and reduced their price target for the company from $43.00 to $35.00 in a research report on Friday, February 28th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and six have assigned a buy rating to the stock. Based on data from MarketBeat, Acadia Healthcare presently has an average rating of “Moderate Buy” and an average target price of $50.39.

Acadia Healthcare Stock Performance

ACHC stock traded down $2.19 during midday trading on Wednesday, hitting $26.91. 702,961 shares of the company traded hands, compared to its average volume of 1,930,046. The company has a quick ratio of 1.07, a current ratio of 1.07 and a debt-to-equity ratio of 0.60. The business has a 50 day simple moving average of $33.96 and a 200-day simple moving average of $41.87. The stock has a market capitalization of $2.50 billion, a price-to-earnings ratio of 8.76, a price-to-earnings-growth ratio of 1.46 and a beta of 1.13. Acadia Healthcare has a twelve month low of $25.41 and a twelve month high of $82.40.

Hedge Funds Weigh In On Acadia Healthcare

Large investors have recently bought and sold shares of the business. Wellington Management Group LLP boosted its stake in Acadia Healthcare by 0.7% during the 4th quarter. Wellington Management Group LLP now owns 11,734,743 shares of the company’s stock worth $465,283,000 after acquiring an additional 76,490 shares during the last quarter. FMR LLC grew its holdings in shares of Acadia Healthcare by 257.9% in the 4th quarter. FMR LLC now owns 6,230,631 shares of the company’s stock valued at $247,045,000 after acquiring an additional 4,489,681 shares in the last quarter. Dimensional Fund Advisors LP increased its position in shares of Acadia Healthcare by 18.0% during the 4th quarter. Dimensional Fund Advisors LP now owns 3,182,729 shares of the company’s stock worth $126,189,000 after purchasing an additional 486,395 shares during the last quarter. JPMorgan Chase & Co. increased its holdings in Acadia Healthcare by 17.0% during the third quarter. JPMorgan Chase & Co. now owns 3,126,607 shares of the company’s stock worth $198,258,000 after buying an additional 454,044 shares during the last quarter. Finally, State Street Corp raised its holdings in shares of Acadia Healthcare by 3.5% in the 3rd quarter. State Street Corp now owns 2,819,911 shares of the company’s stock valued at $178,811,000 after purchasing an additional 95,613 shares during the period.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.